<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_CIEI-BJ_Proof skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:CIEI-BJ/Proof</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Template</TITLE></P><NAV id="mainNav" class="navbar navbar-default navbar-inverse" style="font-family:Lato;font-size:22px;background-color:#2196f3;-webkit-transform: translateZ(0);z-index: 100;position: fixed;box-shadow: 0px 0px 10px black;"><DIV id="TopBar" class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav"><LI><A href="https://2016.igem.org/Team:CIEI-BJ">Home Page</A></LI><LI><A id="t1" onmouseover="javascript:showsecond(this,'mydiv2');" onmouseout="dalayedHide1(this,'mydiv1')">Team</A></LI><LI><A id="t2" onmouseover="javascript:showfirst(this,'mydiv1');" onmouseout="dalayedHide2(this,'mydiv2')">Project</A></LI><LI><A id="t3" onmouseover="javascript:showthird(this,'mydiv3');" onmouseout="dalayedHide3(this,'mydiv3')">Parts</A></LI><LI><A id="t4" onmouseover="javascript:showforth(this,'mydiv4');" onmouseout="dalayedHide4(this,'mydiv4')">Safety</A></LI><LI><A id="t6" onmouseover="javascript:showsixth(this,'mydiv6');" onmouseout="dalayedHide6(this,'mydiv6')">Human Practices</A></LI></UL></DIV></DIV></NAV></DIV><DIV class="container well" id="mydiv2" style="border:1px solid silver;display:none; margin-top: 0px;"><DIV class="row"><P> </P><P> </P><DIV class="col-lg-4 col-md-4 col-sm-6"><DIV class="media"><DIV class="media-body"><H2 class="media-heading"><A href="https://2016.igem.org/Team:CIEI-BJ/Team">Meet the Team</A></H2><P>Meet that passionate team!!</P></DIV></DIV></DIV><DIV class="col-lg-4 col-md-4 col-sm-6"><DIV class="media"><DIV class="media-body"><H2 class="media-heading"><A href="https://2016.igem.org/Team:CIEI-BJ/Collaborations">Collaboration</A></H2><P>See how we work together.</P></DIV></DIV></DIV><DIV class="media-body"><H2 class="media-heading"><A href="https://2016.igem.org/Team:CIEI-BJ/Attributions">Attributions</A></H2><H2 class="media-heading"> </H2></DIV></DIV></DIV><DIV class="container well" id="mydiv4" style="border:1px solid silver;display:none;margin-top: 0px;"><DIV class="row"><P> </P><P> </P><DIV class="col-lg-4 col-md-4 col-sm-6"><DIV class="media"><DIV class="media-body"><H2 class="media-heading"><A href="https://2016.igem.org/Team:CIEI-BJ/Safety">Safety First!</A></H2>
          Safety is always our first priority.</DIV></DIV></DIV><P> </P><P> </P><P> </P><P> </P></DIV></DIV><DIV class="container well" id="mydiv5" style="border:1px solid silver;display:none;margin-top: 0px;"><DIV class="row"><DIV class="col-lg-4 col-md-4 col-sm-6"><P> </P><P> </P><P> </P><DIV class="media"><DIV class="media-body"><H2 class="media-heading"><A href="https://2016.igem.org/Team:CIEI-BJ/Attributions">Attributions</A></H2>
          The Attribution requirement tells what we did ourselves and what we had help with. </DIV></DIV></DIV><P> </P><P> </P><P> </P><P> </P></DIV></DIV><DIV class="container well" id="mydiv6" style="border:1px solid silver;display:none;margin-top: 0px;"><DIV class="row"><DIV class="col-lg-4 col-md-4 col-sm-6"><P> </P><P> </P><DIV class="media"><DIV class="media-body"><H2 class="media-heading"><A href="https://2016.igem.org/Team:CIEI-BJ/Human_Practices">Human Practices</A></H2>
          This part is our social and environmental context, in order to help us better understand issues that might influence the design and use of our technologies. </DIV></DIV></DIV><P> </P><P> </P><P> </P><P> </P></DIV></DIV><DIV class="container well" id="mydiv7" style="border:1px solid silver;display:none;margin-top: 0px;"><DIV class="row"><DIV class="col-lg-4 col-md-4 col-sm-6"><P> </P><P> </P><DIV class="media"><DIV class="media-body"><H2 class="media-heading"><A href="https://2016.igem.org/Team:CIEI-BJ/Model">Model</A></H2>
          Here's our model to prove our results and help us finish the experiment.</DIV></DIV></DIV><P> </P><P> </P><P> </P><P> </P></DIV></DIV><P><A href="#0" class="cd-top cd-is-visible cd-fade-out">Top</A></P><DIV class="container well" id="mydiv1" style="border:1px solid silver;display:none;margin-top: 0px;"><P>Tanshinone will decrease blood pressure, dilate the arteries and reduce blood clotting.</P><TABLE width="947" height="168" style="border:1px #f5f5f5 solid;"><TBODY><TR><TH width="99" scope="col" style="border:1px transparent solid;"><A href="https://2016.igem.org/Team:CIEI-BJ/Description#description">Description</A></TH><TH width="88" scope="col" style="border:1px transparent solid;"><A href="https://2016.igem.org/Team:CIEI-BJ/Description#solution">Design</A></TH><TH width="136" scope="col" style="border:1px transparent solid;"><A href="https://2016.igem.org/Team:CIEI-BJ/Experiments">Experiments</A></TH><TH width="117" scope="col" style="border:1px transparent solid;"><A href="https://2016.igem.org/Team:CIEI-BJ/Notebook">Notebook</A></TH></TR><TR><TD style="border:1px transparent solid;"><A href="https://2016.igem.org/Team:CIEI-BJ/Description#description"> Demonstrate</A></TD><TD style="border:1px transparent solid;"><A href="https://2016.igem.org/Team:CIEI-BJ/Proof">Proof</A></TD><TD style="border:1px transparent solid;"><A href="https://2016.igem.org/Team:CIEI-BJ/Results">Results</A></TD><TD style="border:1px transparent solid;"> </TD><TD style="border:1px transparent solid;"> </TD></TR></TBODY></TABLE></DIV><P> </P><DIV class="container well" id="mydiv3" style="border:1px solid silver;margin-top: 0px;display:none;"><TABLE width="952" height="80" style="border:1px transparent solid;"><TBODY><TR><TH width="860" scope="col" style="border:1px transparent solid;"><H1><A href="https://2016.igem.org/Team:CIEI-BJ/Parts">All Parts</A></H1></TH></TR></TBODY></TABLE></DIV><P><TITLE>Safety</TITLE></P><DIV class="container" style="z-index:10;position:relative;"><DIV id="bodycontainer" class="row card"><DIV class="col-sm-10"><DIV class="row"><DIV class="col-sm-12" id="background"><H1 style="left:" 50=""><SPAN class="toptitle">Our Idea</SPAN></H1><P style="left:" 50=""> </P></DIV></DIV><DIV class="row" id="environmental_safety"><DIV class="col-sm-10 col-sm-offset-1"><H3 class="block_header red" style="padding-top: 50px"><STRONG>What's our idea?</STRONG></H3><UL><LI><P><STRONG>Our idea</STRONG></P><P>SmCPS1 is the first and one of the most important enzymes in Tanshinone synthesis. It  converts geranyl geranyl pyrophosphate(GGPP) into copalyl diphosphate (CPP).  </P><P>To produce the enzyme SmCPS1 through synthetic biology, we constructed the gene circuit above. tac promotor, a strong hybrid promotor, is used to control and increase the <A href="https://www.isnare.com/encyclopedia/Gene_expression">expression</A> levels of a target gene and is used in the <A href="https://www.isnare.com/encyclopedia/Over-expression">over-expression</A> of <A href="https://www.isnare.com/encyclopedia/Recombinant_proteins">recombinant proteins</A>, produced from the combination of promotors from the trp and lac operons.
                              Thrombin protease and TEV are the two type of restriction enzyme cleavage sites which can let SmCPS1 gene insert in between and later help the SmCPS1 enzyme to be purified. GFP was used to test the expression of our target gene SmCPS1. The target gene (SmCPS1) was obtained from Institute of Botany, Chinese academy of Science. </P><P>In our research, we used pGEX-KG as the vector of our Biobrick device. It basically composes of Ampicillin anti-fragment, lac promoter with different primers, and tac promoter followed by multiple cloning site, which offers a favorable system to further insert our target DNA (SmCPS1) via pre-existed thrombin protease and newly added TEV.</P><P> </P><P> </P><P> </P><P> </P><P> </P><P> </P><P> </P><P>To avoid our target gene be digested by the restriction enzyme after we combine it with the plasmid iGEM provide, we did site-directed mutagenesis</P><P><STRONG> </STRONG></P><P><STRONG>Our method</STRONG></P></LI></UL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>